Ryan Zimmerman analyst BTIG

Currently out of the existing stock ratings of Ryan Zimmerman, 400 are a BUY (89.29%), 44 are a HOLD (9.82%), 4 are a SELL (0.89%).

Ryan Zimmerman

Work Performance Price Targets & Ratings Chart

Analyst Ryan Zimmerman, currently employed at BTIG, carries an average stock price target met ratio of 54.89% that have a potential upside of 36.73% achieved within 257 days.

Ryan Zimmerman’s has documented 850 price targets and ratings displayed on 40 stocks. The coverage is on Healthcare, Financial Services sectors.

Most recent stock forecast was given on GEHC, GE HealthCare Technologies at 17-Sep-2026.

Wall Street Analyst Ryan Zimmerman

Analyst best performing recommendations are on RXST (RXSIGHT).
The best stock recommendation documented was for RXST (RXSIGHT) at 1/7/2024. The price target of $43 was fulfilled within 1 day with a profit of $6.11 (16.56%) receiving and performance score of 165.63.

Average potential price target upside

ALC Alcon AG GKOS Glaukos Corp GMED Globus Medical HUMA Humacyte IART Integra LifeSciences Holdings ISRG Intuitive Surgical KIDS Orthopediatrics Corp MDWD Mediwound Ltd MSON Misonix NUVA NuVasive ORGO Organogenesis Holdings PEN Penumbra RXST Rxsight SPNE SeaSpine Holdings Corp SRGA Surgalign Holdings SYK Stryker TCMD Tactile Systems Technology VCEL Vericel Corp Ord ZBH Zimmer Biomet Holdings HOLX Hologic MDT Medtronic PLC ABT Abbott Laboratories TMCI Treace Medical Concepts STAA STAAR Surgical Company RBOT Vicarious Surgical RCEL Avita Medical Ltd OFIX Orthofix Medical GEHC GE HealthCare Technologies MDAI Spectral AI AXGN Axogen CFMS ConforMIS PRCT Procept Biorobotics Corp SI Silvergate Capital LNSR ECOR Electrocore LLC ENOV Enovis Corp SOLV Solventum Corp. XTNT IRTC iRhythm Technologies PODD Insulet

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 08-Apr-2022

$98

$33.53 (52.01%)

$98

16 days ago
(15-Sep-2026)

13/31 (41.94%)

$30.24 (44.63%)

399

Hold Since 12-Aug-2026

$78.4

$13.93 (21.61%)

$77.53

1 months 19 days ago
(12-Aug-2026)

5/7 (71.43%)

$4.82 (6.55%)

86

Buy Since 15-Apr-2019

$85

$20.53 (31.84%)

$80

1 months 19 days ago
(12-Aug-2026)

9/19 (47.37%)

$11.42 (15.52%)

413

Buy Since 17-Oct-2022

$82

$17.53 (27.19%)

$82

1 months 20 days ago
(11-Aug-2026)

12/23 (52.17%)

$6.65 (8.83%)

108

Hold Since 13-Oct-2025

$78

$13.53 (20.99%)

$90

4 months 23 days ago
(08-May-2026)

11/13 (84.62%)

$15.44 (24.68%)

571

Show more analysts

Please expand the browser size to see the chart

Which stock is Ryan Zimmerman most bullish on?

Potential upside of $82.61 has been obtained for SYK (STRYKER)

Which stock is Ryan Zimmerman most reserved on?

Potential downside of -$0.84 has been obtained for RCEL (AVITA MEDICAL LTD)

What Year was the first public recommendation made by Ryan Zimmerman?

On 2017
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?